Kevin Strong will serve as CFO and Deena Siblock takes on Corporate Secretary role, adding capacity and talent to the fast-growing healthcare technology leader, Avricore Health. Vancouver, May XX, 2019 – Avricore Health Inc. (TSXV: AVCR) (OTCBB: AVCR) (“Avricore Health”) is expanding its capacity to meet its objectives by adding

Avricore Health Inc. (TSXV:  AVCR) (“Avricore Health”) has signed a distribution agreement with Molecular You Corporation (“Molecular You”) to provide its newly developed genetic medication response test myCannabisPGxTM, which is designed to ensure safe and effective use of medical cannabis in a community pharmacy setting. During this launch phase, Avricore

Avricore Health offers products and services to empower and educate pharmacists   Government action on drug pricing has had unintended consequences for community pharmacies and health care Avricore Health’s offering helps pharmacists grow revenues, enhance role in customer care HealthTabTM allows quick access to health biomarkers, personalized genomic information The Government

Government action on drug pricing has had unintended consequences for community pharmacies and healthcare Avricore Health’s offering helps pharmacists grow revenues, enhance role in customer care HealthTab™ allows quick access to health biomarkers, personalized genomic information The Government of Canada’s recent actions to take costs out of the health care

Avricore Health Inc. Advisory Board Welcomes Mark Zhou Pharmacy practice specialist and McKesson representative brings talent and expertise to Avricore’s strategic development and client education team Vancouver, March 18, 2019 (GLOBE NEWSWIRE) — Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is very pleased to announce that Mark Zhou will join

March 15, 2019 – Avricore Health Inc. (“AVCR”), is pleased to announce that further to its news release dated February 13, 2019, it has closed a non-brokered private placement of 4,206,435 common shares (“Common Shares”) of the Company at a price of $0.07 per Common Share for gross proceeds of

Avricore Health Inc. (“AVCR”), announced today a non-brokered private placement of up to 14,285,714 common shares at a price of $0.07 per common share for gross proceeds of up to $1,000,000 (the “Offering”). The Company may pay a finder’s fee on the Offering within the amount permitted by the policies

Avricore Health Inc. (TSX-V: AVCR) (OTCQB: AVCRF) (“Avricore Health” or the “Company”) Dear Shareholders: Thank you for your continued support of Avricore Health. We know this market has been challenging for our industry and our shareholders alike; however, we have had an exciting year and are poised for success in

Avricore Health Inc. Advisory Board Welcomes Hector Bremner Communications professional and former advisor to BC Deputy Premier and Vancouver City Councillor will support Strategic and Government Affairs Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is very pleased to announce that Hector Bremner will join the company’s Advisor Board and support